Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.5700
-0.0195 (-3.31%)
At close: Aug 6, 2026
Vaxart Market Cap
Vaxart has a market cap or net worth of $137.54 million as of August 6, 2026. Its market cap has increased by 63.77% in one year.
Market Cap
137.54M
Enterprise Value
88.72M
Revenue
255.61M
Ranking
n/a
PE Ratio
3.61
Stock Price
$0.57
ChartMarket Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from 60.35M to 137.54M, an increase of 127.90%. That is a compound annual growth rate of 10.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 137.54M | 65.45% |
| Dec 31, 2025 | 83.13M | -44.81% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 276.84M |
| CytoDyn | 256.81M |
| Glorywin Entertainment Group | 182.41M |
| NDT Pharmaceuticals | 104.70M |
| HST Global | 99.00M |
| BioStem Technologies | 59.10M |
| Cell Source | 55.94M |
| Nuo Therapeutics | 48.41M |